1. Home
  2. CGTX vs ARBK Comparison

CGTX vs ARBK Comparison

Compare CGTX & ARBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • ARBK
  • Stock Information
  • Founded
  • CGTX 2007
  • ARBK 2017
  • Country
  • CGTX United States
  • ARBK United Kingdom
  • Employees
  • CGTX N/A
  • ARBK N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • ARBK Finance: Consumer Services
  • Sector
  • CGTX Health Care
  • ARBK Finance
  • Exchange
  • CGTX Nasdaq
  • ARBK Nasdaq
  • Market Cap
  • CGTX 23.1M
  • ARBK 20.1M
  • IPO Year
  • CGTX 2021
  • ARBK 2021
  • Fundamental
  • Price
  • CGTX $0.28
  • ARBK $0.37
  • Analyst Decision
  • CGTX Strong Buy
  • ARBK Hold
  • Analyst Count
  • CGTX 5
  • ARBK 1
  • Target Price
  • CGTX $6.13
  • ARBK N/A
  • AVG Volume (30 Days)
  • CGTX 692.0K
  • ARBK 280.1K
  • Earning Date
  • CGTX 05-07-2025
  • ARBK 05-22-2025
  • Dividend Yield
  • CGTX N/A
  • ARBK N/A
  • EPS Growth
  • CGTX N/A
  • ARBK N/A
  • EPS
  • CGTX N/A
  • ARBK N/A
  • Revenue
  • CGTX N/A
  • ARBK $52,868,000.00
  • Revenue This Year
  • CGTX N/A
  • ARBK N/A
  • Revenue Next Year
  • CGTX N/A
  • ARBK $175.58
  • P/E Ratio
  • CGTX N/A
  • ARBK N/A
  • Revenue Growth
  • CGTX N/A
  • ARBK 18.91
  • 52 Week Low
  • CGTX $0.31
  • ARBK $0.29
  • 52 Week High
  • CGTX $2.95
  • ARBK $1.99
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 31.37
  • ARBK 47.18
  • Support Level
  • CGTX $0.40
  • ARBK $0.35
  • Resistance Level
  • CGTX $0.47
  • ARBK $0.42
  • Average True Range (ATR)
  • CGTX 0.03
  • ARBK 0.03
  • MACD
  • CGTX -0.01
  • ARBK 0.00
  • Stochastic Oscillator
  • CGTX 2.76
  • ARBK 32.77

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About ARBK Argo Blockchain plc

Argo Blockchain PLC is a data center business that provides a powerful and efficient platform for cryptocurrency mining operations. The company has operations in strategic locations in North America.

Share on Social Networks: